Heterogeneity of the Mac-1 expression on peripheral blood neutrophils in patients with different types of epithelial ovarian cancer

Immunobiology

Volumn 221, Issue 2, 2016, Pages 323-332

  Bednarska, Katarzyna ^a   Klink, Magdalena ^a   Wilczyński, Jacek R ^b   Szyłło, Krzysztof ^b   Malinowski, Andrzej ^b   Sułowska, Zofia ^a   Nowak, Marek ^b  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

CD11b; Histological classification; Mac 1; Neutrophil granulocytes; Ovarian cancer

Indexed keywords

CD11B ANTIGEN; L SELECTIN; P SELECTIN GLYCOPROTEIN LIGAND 1; ITGAM PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; TUMOR DIFFERENTIATION; CARCINOMA; CASE CONTROL STUDY; CYSTADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; IMMUNOLOGY; NEOPLASM; OVARY TUMOR; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD11B; CARCINOMA; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HUMANS; L-SELECTIN; MACROPHAGE-1 ANTIGEN; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEUTROPHIL ACTIVATION; NEUTROPHILS; OVARIAN NEOPLASMS; ROC CURVE; SIGNAL TRANSDUCTION;

EID: 84964540385     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.10.003     Document Type: Article

References (34)

1. Absenger, G., Szkandera, J., Pichler, M., Stotz, M., Arminger, F., Weissmueller, M., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., Gerger, A., A derived neutrophils to lymphocytes ratio predicts clinical outcome in stage II and III colon cancer patients. Br. J. Cancer 109:2 (2013), 395–400, 10.1038/bjc.2013.346.
2. Bellati, F., Napoletano, C., Gasparri, M.L., Panici, P.B., Nuti, M., Immunologic systemic effect of neoadjuvant chemotherapy requires investigation before tumor-associated lymphocytes can be introduced in breast cancer treatment algorithm. J. Clin. Oncol. 28:27 (2010), e471–e472, 10.1200/JCO.2010.27.9984 author reply e473.
3. Bellati, F., Napoletano, C., Ruscito, I., Visconti, V., Antonilli, M., Gasparri, M.L., Zizzari, I.G., Rahimi, H., Palaia, I., Rughetti, A., Benedetti Panici, P., Nuti, M., Past, present and future strategies of immunotherapy in gynecological malignancies. Curr. Mol. Med. 13:4 (2013), 648–669.
4. Benedet, J.L., Bender, H., Jones, H. 3rd, Ngan, H.Y., Pecorelli, S., FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70:2 (2000), 209–262.
5. Braicu, E.I., Sehouli, J., Richter, R., Pietzner, K., Denkert, C., Fotopoulou, C., Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br. J. Cancer 105:12 (2011), 1818–1824, 10.1038/bjc.2011.455.
6. Chao, W.R., Lee, M.Y., Lin, W.L., Chen, C.K., Lin, J.C., Koo, C.L., Sheu, G.T., Han, C.P., HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Hum. Pathol. 45:4 (2014), 810–816, 10.1016/j.humpath.2013.11.016.
7. Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B.M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., von Törne, C., Weichert, W., Engels, K., Solbach, C., Schrader, I., Dietel, M., von Minckwitz, G., Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J. Clin. Oncol. 28:1 (2010), 105–113, 10.1200/JCO.2009.23.7370.
8. Donskov, F., von der Maase, H., Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J. Clin Oncol. 24:13 (2006), 1997–2005.
9. Gasparri, M.L., Attar, R., Palaia, I., Perniola, G., Marchetti, C., Di Donato, V., Farooqi, A.A., Papadia, A., Panici, P.B., Tumor infiltrating lymphocytes in ovarian cancer. Asian Pac. J. Cancer Prev. 16:9 (2015), 3635–3638.
10. Heintz, A.P., Odicino, F., Maisonneuve, P., Quinn, M.A., Benedet, J.L., Creasman, W.T., Ngan, H.Y., Pecorelli, S., Beller, U., Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. Int. J. Gynaecol. Obstet. 95:suppl. 1 (2006), S161–S192.
11. Klink, M., Jastrzembska, K., Nowak, M., Bednarska, K., Szpakowski, M., Szyllo, K., Sulowska, Z., Ovarian cancer cells modulate human blood neutrophils response to activation in vitro. Scand. J. Immunol. 68:3 (2008), 328–336, 10.1111/j.1365-3083.2008.02139.x.
12. Klink, M., Bednarska, K., Blus, E., Kielbik, M., Sulowska, Z., Seasonal changes in activities of human neutrophils in vitro. Inflamm. Res. 61:1 (2012), 11–16, 10.1007/s00011-011-0382-x.
13. Kurman, R.J., Shih, IeM, Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 27:2 (2008), 151–160, 10.1097/PGP.0b013e318161e4f5.
14. Kurman, R.J., Shih, IeM, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum. Pathol. 42:7 (2011), 918–931.
15. Kurose, I., Anderson, D.C., Miyasaka, M., Tamatani, T., Paulson, J.C., Todd, R.F., Rusche, J.R., Granger, D.N., Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res. 74:2 (1994), 336–343.
16. Nowak, M., Klink, M., Glowacka, E., Sulowska, Z., Kulig, A., Szpakowski, M., Szyllo, K., Tchorzewski, H., Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells. Scand. J. Immunol. 71:2 (2010), 91–98, 10.1111/j.1365-3083.2009.02350.x.
17. Patriarca, C., Macchi, R.M., Marschner, A.K., Mellstedt, H., Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat. Rev. 38:1 (2012), 68–75, 10.1016/j.ctrv.2011.04.002.
18. Prat, J., FIGO Committee on Gynecologic Oncology, Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynaecol. Obstet. 1 (2014), 1–5.
19. Schymeinsky, J., Mócsai, A., Walzog, B., Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb. Haemost. 98:2 (2007), 262–273.
20. Shih, IeM, Kurman, R.J., Ovarian tumourigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164:5 (2004), 1511–1518.
21. Spicer, J.D., McDonald, B., Cools-Lartigue, J.J., Chow, S.C., Giannias, B., Kubes, P., Ferri, L.E., Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res. 72:16 (2012), 3919–3927, 10.1158/0008-5472 CAN-11-2393.
22. Spizzo, G., Went, P., Dirnhofer, S., Obrist, P., Moch, H., Baeuerle, P.A., Mueller-Holzner, E., Marth, C., Gastl, G., Zeimet, A.G., Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol. Oncol. 103:2 (2006), 483–488.
23. Starkey, J.R., Liggitt, H.D., Jones, W., Hosick, H.L., Influence of migratory blood cells on the attachment of tumour cells to vascular endothelium. Int. J. Cancer. 34:4 (1984), 535–543.
24. Steeber, D.A., Engel, P., Miller, A.S., Sheetz, M.P., Tedder, T.F., Ligation of L-selectin through conserved regions within the lectin domain activates signal transduction pathways and integrin function in human, mouse, and rat leukocytes. J. Immunol. 159:2 (1997), 952–963.
25. Tandon, P., Diamond, S.L., Kinetics of beta2-integrin and L-selectin bonding during neutrophil aggregation in shear flow. Biophys. J. 75:6 (1998), 3163–3178.
26. Turan, G., Usta, C.S., Usta, A., Kanter, M., Tavli, L., Karacan, M., Celik, C., Eser, M., The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables. J. Mol. Histol. 45:6 (2014), 679–687, 10.1007/s10735-014-9591-2.
27. Verri, E., Guglielmini, P., Puntoni, M., Perdelli, L., Papadia, A., Lorenzi, P., Rubagotti, A., Ragni, N., Boccardo, F., HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology 68:2–3 (2005), 154–161 EpubJul 11.
28. Wang, D., Yang, J.X., Cao, D.Y., Wan, X.R., Feng, F.Z., Huang, H.F., Shen, K., Xiang, Y., Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther. 6 (2013), 211–216, 10.2147/ott.s41711.
29. Watanabe, T., Shibata, M., Nishiyama, H., Soeda, S., Furukawa, S., Gonda, K., Takenoshita, S., Fujimori, K., Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer. Oncol. Lett. 7:2 (2014), 373–377.
30. Welch, D.R., Schissel, D.J., Howrey, R.P., Aeed, P.A., Tumour-elicited polymorphonuclear cells, in contrast to normal circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 86:15 (1989), 5859–5863.
31. Williams, M.R., Azcutia, V., Newton, G., Alcaide, P., Luscinskas, F.W., Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol. 32:10 (2011), 461–469, 10.1016/j.it.2011.06.009 Review.
32. Williams, K.A., Labidi-Galy, S.I., Terry, K.L., Vitonis, A.F., Welch, W.R., Goodman, A., Cramer, D.W., Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol. Oncol. 132:3 (2014), 542–550, 10.1016/j.ygyno.2014.01.026.
33. Wu, Q.D., Wang, J.H., Condron, C., Bouchier-Hayes, D., Redmond, H.P., Human neutrophils facilitate tumour cell transendothelial migration. Am. J. Physiol. Cell Physiol. 280:4 (2001), C814–C822.
34. Yildirim, M., Demir Cendek, B., Filiz Avsar, A., Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios. Mol. Clin. Oncol. 3:2 (2015), 317–321.